Skip to main content
Clinical Trials/NCT02642796
NCT02642796
Completed
N/A

Comparison of the Efficacy of Two Different Transcutaneous Electrical Nerve Stimulation Application Sites in Reducing Postoperative Pain After Hip Fracture Surgery

Mustafa Kemal University1 site in 1 country120 target enrollmentMarch 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
Mustafa Kemal University
Enrollment
120
Locations
1
Primary Endpoint
Visual analog scale for pain
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Aim of the study to assess the efficacy of two modes of transcutaneous electrical nerve stimulation (TENS) on relief of postoperative acute pain after hip fracture surgery.

Detailed Description

The patients underwent undergo fractured hip surgery will be distributed into three groups with respect to the mode of postoperative analgesia applied: Group I (control): PCA only; group II: PCA plus lumbar plexus \& sciatic nerve TENS (LS-TENS); group III: PCA plus surgical wound TENS (SW-TENS). TENS will be applied every 2 hours for 30-40 minutes during 48 hours postoperatively. Visual analogue score (VAS), Ramsey sedation scores, frequencies of PCA demand and counts of PCA delivery, as well as total analgesic consumption will be noted and compared between groups at various time intervals. Visual analog scale (VAS) will be applied at 2 months postoperatively VAS and Mcgill pain questionnaire will be applied at the 6th and 24th months of the surgery to assess acute and chronic pain in the study population and the differences among groups.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
September 1, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

MENEKSE OKSAR

Assistant Professor

Mustafa Kemal University

Eligibility Criteria

Inclusion Criteria

  • Adult patients will be scheduled for surgery due to hip fracture in Mustafa Kemal University Hospital will be included in the study.

Exclusion Criteria

  • Patients with a history of opioid analgesic abuse, or sensitivity to opioids, and those with clinically significant systemic (cardiovascular, pulmonary, hepatic, renal, neurologic etc.) diseases, will be excluded.

Outcomes

Primary Outcomes

Visual analog scale for pain

Time Frame: 48 h postoperatively

Postoperative pain intensity is assessed using VAS for pain postoperatively.

Secondary Outcomes

  • Frequencies of PCA demand(48 h postoperatively)
  • Ramsey sedation scores(48 h postoperatively)
  • Total fentanyl consumption(48 h postoperatively)
  • PCA delivery counts(48 h postoperatively)

Study Sites (1)

Loading locations...

Similar Trials